Cefazolin for Injection USP and Dextrose Injections USP — Class I drug recall D-1268-2014
Terminated recall by B. Braun Medical Inc, reported 2014-05-07, distributed nationwide. Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible
| Recall number | D-1268-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | B. Braun Medical Inc, Irvine, CA, United States |
| Recall initiated | 2013-11-21 |
| Classified | 2014-04-25 |
| Reported by FDA | 2014-05-07 |
| Terminated | 2014-12-04 |
| Distributed | Nationwide (US) |
| Countries outside the US | ES |
| Quantity | 136,392 units |
| Reason classes | specification failure |
| NDC | 00264-3103, 00264-3103-11, 00264-3105, 00264-3105-11, 00264-3107, 00264-3107-11 |
| Lot numbers | 01/15, 07/14, 11/14, 12/14, H2S725, H2S726, H3D724, H3E724, H3H507 |
| Model numbers | 3103-11 |
Product
Cefazolin for Injection USP and Dextrose Injections USP, 1 g in Duplex, 50 mL Container, Catalog Number 3103-11, For IV Use Only, Sterile, Single Dose, Rx Only, B Braun Medical Inc., Irvine CA 92614-5895, NDC 0264-3103-11
Reason for recall
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1268-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.